• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Research news: New compound blocks 'gatekeeper' enzyme to kill malaria

Emily

Editor, Senior Moderator
http://www.sciencedaily.com/releases/2014/07/140701145712.htm
ScienceDaily: Your source for the latest research news
Featured Research
from universities, journals, and other organizations
New compound blocks 'gatekeeper' enzyme to kill malaria
Date:
July 1, 2014
Source:
Walter and Eliza Hall Institute
Summary:
Researchers are homing in on a new target for malaria treatment, after developing a compound that blocks the action of a key 'gatekeeper' enzyme essential for malaria parasite survival. The compound, called WEHI-916, is the first step toward a new class of antimalarial drugs that could cure and prevent malaria infections caused by all species of the parasite, including those resistant to existing drugs.
...
Journal Reference:

Brad E. Sleebs, Sash Lopaticki, Danushka S. Marapana, Matthew T. O'Neill, Pravin Rajasekaran, Michelle Gazdik, Svenja G?nther, Lachlan W. Whitehead, Kym N. Lowes, Lea Barfod, Lars Hviid, Philip J. Shaw, Anthony N. Hodder, Brian J. Smith, Alan F. Cowman, Justin A. Boddey. Inhibition of Plasmepsin V Activity Demonstrates Its Essential Role in Protein Export, PfEMP1 Display, and Survival of Malaria Parasites. PLoS Biology, 2014; 12 (7): e1001897 DOI: 10.1371/journal.pbio.1001897
 
Back
Top Bottom